China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Price:
27.96
CNY
-0.11%
Market Closed
Market Cap:
¥46.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
|
CN |
|
P
|
PENN Entertainment Inc
SWB:PN1
|
US |
|
G
|
Greenpanel Industries Ltd
NSE:GREENPANEL
|
IN |
|
S
|
South Malaysia Industries Bhd
KLSE:SMI
|
MY |
|
Prime Securities Ltd
NSE:PRIMESECU
|
IN |
|
Yalla Group Ltd
NYSE:YALA
|
AE |
|
Zhongtai Securities Co Ltd
SSE:600918
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 27.96 CNY,
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
|
46.5B CNY | 1.6 | 16.9 | 11.1 | 11.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.8B GBP | 5.2 | 29.6 | 16.4 | 23.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
